Implementation of HIV and Tuberculosis Diagnostics: The Importance of Context

被引:7
|
作者
Dominique, Joyelle K. [1 ]
Ortiz-Osorno, Alberto A. [2 ,3 ]
Fitzgibbon, Joseph [3 ]
Gnanashanmugam, Devasena [4 ]
Gilpin, Christopher [5 ]
Tucker, Timothy [6 ]
Peel, Sheila [7 ]
Peter, Trevor [8 ]
Kim, Peter [4 ]
Smith, Steven [9 ]
机构
[1] Off Sci Management & Operat, Office Global Res, Rockville, MD USA
[2] Henry M Jackson Fdn, Div Aids, Clin Res Implementat Subject Matter Expert, Rockville, MD USA
[3] NIAID, Therapeut Res Program, Div Aids, US Dept Hlth & Human Serv,NIH, Rockville, MD 20892 USA
[4] Div Aids, Prevent Sci Program, Adolescent & Pediat Res Branch, Geneva, Switzerland
[5] WHO, CH-1211 Geneva, Switzerland
[6] Advisory & Dev Consulting, Strateg Evaluat, Cape Town, South Africa
[7] Walter Reed Army Inst Res, US Mil HIV Res Program, Diagnost & Lab Monitoring, Silver Spring, MD USA
[8] Clinton Hlth Access Initiat, Diagnost, Gaborone, Botswana
[9] US Dept Hlth & Human Serv, Off Global Affairs, Pretoria, South Africa
关键词
diagnostics; HIV; tuberculosis; diagnostics' implementation; point-of-care; XPERT MTB/RIF; COST-EFFECTIVENESS; ANTIRETROVIRAL THERAPY; HEALTH SYSTEMS; CARE; TESTS; STANDARDIZATION; SETTINGS; TANZANIA; AFRICA;
D O I
10.1093/cid/civ552
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Novel diagnostics have been widely applied across human immunodeficiency virus (HIV) and tuberculosis prevention and treatment programs. To achieve the greatest impact, HIV and tuberculosis diagnostic programs must carefully plan and implement within the context of a specific healthcare system and the laboratory capacity. Methods. A workshop was convened in Cape Town in September 2014. Participants included experts from laboratory and clinical practices, officials from ministries of health, and representatives from industry. Results. The article summarizes best practices, challenges, and lessons learned from implementation experiences across sub-Saharan Africa for (1) building laboratory programs within the context of a healthcare system; (2) utilizing experience of clinicians and healthcare partners in planning and implementing the right diagnostic; and (3) evaluating the effects of new diagnostics on the healthcare system and on patient health outcomes. Conclusions. The successful implementation of HIV and tuberculosis diagnostics in resource-limited settings relies on careful consideration of each specific context.
引用
收藏
页码:S119 / S125
页数:7
相关论文
共 50 条
  • [31] Importance and implementation of radiological modalities in the diagnostics of soft tissue tumors
    Grund, Caroline
    Kerner, Dorothea
    Driulini, Deborah
    Schneider, Guenther
    RADIOLOGIE, 2024, : 728 - 738
  • [32] Latent Tuberculosis and HIV Infection
    Bares, Sara H.
    Swindells, Susan
    CURRENT INFECTIOUS DISEASE REPORTS, 2020, 22 (07)
  • [33] The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis
    Harries, A. D.
    Lin, Y.
    Satyanarayana, S.
    Loennroth, K.
    Li, L.
    Wilson, N.
    Chauhan, L. S.
    Zachariah, R.
    Baker, M. A.
    Jeon, C. Y.
    Murray, M. B.
    Maher, D.
    Bygbjerg, I. C.
    Enarson, D. A.
    Billo, N. E.
    Kapur, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (11) : 1436 - 1444
  • [34] Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles
    Denkinger, Claudia M.
    Schumacher, Samuel G.
    Gilpin, Christopher
    Korobitsyn, Alexei
    Wells, William A.
    Pai, Madhukar
    Leeflang, Mariska
    Steingart, Karen R.
    Bulterys, Michelle
    Schunemann, Holger
    Glaziou, Philippe
    Weyer, Karin
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S91 - S98
  • [35] Tuberculosis and HIV Coinfection Preface
    Gray, Jacob M.
    Cohn, David L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (01) : 32 - 43
  • [36] HIV-associated pediatric tuberculosis: prevention, diagnosis and treatment
    Kay, Alexander
    Garcia-Prats, Anthony J.
    Mandalakas, Anna Maria
    CURRENT OPINION IN HIV AND AIDS, 2018, 13 (06) : 501 - 506
  • [37] Potential Market for Novel Tuberculosis Diagnostics: Worth the Investment?
    Kik, Sandra V.
    Denkinger, Claudia M.
    Jefferson, Carole
    Ginnard, Janet
    Pai, Madhukar
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 : S58 - S66
  • [38] Diagnostics for tuberculosis: what test developers want to know
    Pai, Madhukar
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (04) : 311 - 314
  • [39] Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
    Sabur, Natasha F.
    Esmail, Aliasgar
    Brar, Mantaj S.
    Dheda, Keertan
    BMC INFECTIOUS DISEASES, 2017, 17
  • [40] New tuberculosis diagnostics and rollout
    McNerney, Ruth
    Cunningham, Jane
    Hepple, Pamela
    Zumla, Alimuddin
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 32 : 81 - 86